|
Volumn 45, Issue 3, 2014, Pages 880-883
|
Thrombelastography detects the anticoagulant effect of rivaroxaban in patients with stroke
|
Author keywords
Factor Xa; Rivaroxaban; Stroke; Thrombolytic therapy
|
Indexed keywords
BLOOD CLOTTING FACTOR 10A INHIBITOR;
RIVAROXABAN;
ANTICOAGULANT AGENT;
BLOOD CLOTTING FACTOR 10A;
BLOOD CLOTTING FACTOR 11;
MORPHOLINE DERIVATIVE;
THIOPHENE DERIVATIVE;
ACTION POTENTIAL;
ADULT;
AGED;
ANTICOAGULATION;
ARTICLE;
BLOOD CLOT LYSIS;
BRAIN ISCHEMIA;
CEREBROVASCULAR ACCIDENT;
CLINICAL ARTICLE;
CONTROLLED STUDY;
EMERGENCY CARE;
FEMALE;
HEART ATRIUM FIBRILLATION;
HEMATOLOGY ANALYZER;
HUMAN;
MALE;
MIDDLE AGED;
PRIORITY JOURNAL;
SINGLE DRUG DOSE;
STROKE PATIENT;
THROMBOELASTOGRAPHY;
BLOOD;
BLOOD CLOTTING;
DRUG ANTAGONISM;
DRUG EFFECT;
FIBRINOLYTIC THERAPY;
METHODOLOGY;
STATISTICS;
FACTOR XA;
RIVAROXABAN;
STROKE;
THROMBOLYTIC THERAPY;
AGED;
ANTICOAGULANTS;
BLOOD COAGULATION;
FACTOR XI;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MORPHOLINES;
STROKE;
THIOPHENES;
THROMBELASTOGRAPHY;
THROMBOLYTIC THERAPY;
|
EID: 84899131115
PISSN: 00392499
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/STROKEAHA.113.004016 Document Type: Article |
Times cited : (29)
|
References (6)
|